Adelina is an epidemiologist and her research is focused on the prevention of hepatitis C, HIV, overdose and other drug-related harms. Currently, her work is focused on exploring strategies for measuring and reducing HCV and HIV transmission in different risk groups using epidemic modelling, evidence synthesis and longitudinal methods.

Dr Falade-Nwulia is an Associate Professor in the Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA. She is a clinical provider and conducts implementation science research on approaches to increase uptake of integrated hepatitis, HIV and substance use disorder treatment for people who use drugs.

Anne Drost has been a nurse for over 30 years. For the last 22 years she has worked at Cool Aid Community Health Centre in the inner city of Victoria, BC, Canada. Anne is particularly interested in mental health and addictions and the intersection of these with the infectious diseases of HIV and Hepatitis.

Dr Falade-Nwulia is an Associate Professor in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. Her research focuses on understanding barriers to HCV, HIV and Substance use disorder (SUD) care uptake and use of implementation science approaches to improve HIV, HCV and SUD treatment services for people who use drugs.

Malika Zafar, Executive Director, Nai Zindagi, led a team that expanded HIV treatment and prevention to 62 districts, launched services in prisons, implemented point of care viral load testing, initiated Hepatitis C testing and treatment, and established mobile ARV delivery, enhancing care for people who inject drugs and their partners.